Emerging role of immunogenic cell death in cancer immunotherapy.
Arimoto KI, Miyauchi S, Liu M, Zhang DE.
Arimoto KI, et al.
Front Immunol. 2024 May 10;15:1390263. doi: 10.3389/fimmu.2024.1390263. eCollection 2024.
Front Immunol. 2024.
PMID: 38799433
Free PMC article.
Review.
Our recent findings are also highlighted, revealing a mode of ICD induction facilitated by atypical interferon (IFN)-stimulated genes (ISGs), including polo-like kinase 2 (PLK2), during hyperactive type I IFN signaling. ...
Our recent findings are also highlighted, revealing a mode of ICD induction facilitated by atypical interferon (IFN)-stimulated genes (ISGs) …